✦ LIBER ✦

Lack of drug interaction between the migraine drug MAP0004 (orally inhaled dihydroergotamine) and a CYP3A4 inhibitor in humans

✍ Scribed by Kellerman, D.; Kori, S.; Forst, A.; Chang, J.; Febbraro, S.; WuTann, L.; Thomas, T.; Taylor, G.; Dodick, D.

Book ID: 124099217
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 257 KB
Volume: 32
Category: Article
ISSN: 0333-1024
DOI: 10.1177/0333102411432299

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical importance of the drug interact

Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network

✍ Christopher G. Rowan; Steven M. Brunelli; Jeffrey Munson; James Flory; Peter P. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Lack of a clinically significant drug-dr

Lack of a clinically significant drug-drug interaction in healthy volunteers between the HCV protease inhibitor boceprevir and the proton pump inhibitor omeprazole

✍ de Kanter, C. T. M. M.; Colbers, A. P. H.; Blonk, M. I.; Verweij-van Wissen, C. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 325 KB

Lack of Clinically Relevant Drug–Drug In

Lack of Clinically Relevant Drug–Drug Interaction Between Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, and Verapamil, Ramipril, or Digoxin in Healthy Volunteers

✍ Macha, Sreeraj; Sennewald, Regina; Rose, Peter; Schoene, Katja; Pinnetti, Sabine 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 520 KB

Studies on the Interactions between Drug

Studies on the Interactions between Drugs and Estrogen: Analytical Method for Prediction System of Gynecomastia Induced by Drugs on the Inhibitory Metabolism of Estradiol Using Escherichia coli Coexpressing Human CYP3A4 with Human NADPH-Cytochrome P450 Reductase

✍ Takashi Satoh; Ken-ichi Fujita; Haruka Munakata; Shinji Itoh; Katsunori Nakamura 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 94 KB

To establish a prediction system for drug-induced gynecomastia in clinical fields, a model reaction system was developed to explain numerically this side effect. The principle is based on the assumption that 50% inhibition concentration (IC 50 ) of drugs on the in vitro metabolism of estradiol (E2)